FDA Inspection 790624 — Biocon Biologics Limited

Biocon Biologics Limited — FEI 3003981475

The FDA completed an inspection of Biocon Biologics Limited on Jun 13, 2012 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 13, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.